Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M1 positive allosteric modulator VU0467319 for Alzheimer's disease: a single ascending-dose study in healthy participants. - Conley AC; Key AP; Blackford JU; Russell JK; Albert KM; Gong X; Bubser M; Rook JM; Conn PJ; Lindsley CW; Jones CK; Newhouse PA (Alzheimer's research & therapy, 2025)